IL149471A0 - Vaccines for mycoplasma bovis and methods for immunizing bovine amimals - Google Patents

Vaccines for mycoplasma bovis and methods for immunizing bovine amimals

Info

Publication number
IL149471A0
IL149471A0 IL14947100A IL14947100A IL149471A0 IL 149471 A0 IL149471 A0 IL 149471A0 IL 14947100 A IL14947100 A IL 14947100A IL 14947100 A IL14947100 A IL 14947100A IL 149471 A0 IL149471 A0 IL 149471A0
Authority
IL
Israel
Prior art keywords
amimals
vaccines
methods
mycoplasma bovis
immunizing
Prior art date
Application number
IL14947100A
Other languages
English (en)
Original Assignee
Biomune
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomune filed Critical Biomune
Publication of IL149471A0 publication Critical patent/IL149471A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL14947100A 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods for immunizing bovine amimals IL149471A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16428699P 1999-11-08 1999-11-08
PCT/US2000/042000 WO2001034189A2 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods of use

Publications (1)

Publication Number Publication Date
IL149471A0 true IL149471A0 (en) 2002-11-10

Family

ID=22593810

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14947100A IL149471A0 (en) 1999-11-08 2000-11-08 Vaccines for mycoplasma bovis and methods for immunizing bovine amimals

Country Status (10)

Country Link
US (7) US7943153B1 (enExample)
EP (1) EP1229929A2 (enExample)
JP (1) JP2003513935A (enExample)
AU (1) AU782508B2 (enExample)
BR (1) BR0015398A (enExample)
CA (1) CA2390613A1 (enExample)
IL (1) IL149471A0 (enExample)
MX (1) MXPA02004627A (enExample)
WO (1) WO2001034189A2 (enExample)
ZA (1) ZA200203622B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
GB0110851D0 (en) * 2001-05-03 2001-06-27 Mini Agriculture & Fisheries Vaccine
US20030147914A1 (en) * 2001-07-02 2003-08-07 Pfizer Inc. Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
BR0211563A (pt) * 2001-08-28 2004-07-13 Pfizer Prod Inc Modelo de infecção por mycoplasma bovis e métodos para administração de m. bovis e para indução de lesões pneumÈnicas do pulmão
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
CL2008003202A1 (es) 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
US9056909B2 (en) * 2007-11-06 2015-06-16 Zoetis Services Llc Mycoplasma hyopneumoniae avirulent adjuvanted live vaccine
EP2163239A1 (de) * 2008-05-27 2010-03-17 Qiagen GmbH Produkte, die Biopartikel enthalten, Verfahren zu ihrer Herstellung
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
SG10201506597RA (en) 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
WO2011044576A2 (en) 2009-10-09 2011-04-14 Children's Medical Center Corporation Selectively disrupted whole-cell vaccine
EP2621951A1 (en) * 2010-09-29 2013-08-07 Université de Liège Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis
US9052315B2 (en) 2012-05-09 2015-06-09 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
US10359614B2 (en) 2012-07-03 2019-07-23 Advanced Animal Diagnostics, Inc. Diagnostic apparatus
HUE059179T2 (hu) 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US9797893B2 (en) 2013-05-09 2017-10-24 Advanced Animal Diagnostics, Inc. Rapid detection of analytes in liquid samples
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN113040094B (zh) * 2021-03-18 2022-06-21 中国农业大学 一种牛支原体性小鼠乳腺炎模型的构建方法及其应用
CN116751723A (zh) * 2023-07-24 2023-09-15 吉林农业大学 一种牛支原体菌株及其灭活疫苗和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043272B1 (en) 1980-07-01 1984-06-13 National Research Development Corporation Production of viral antigens
US4425330A (en) * 1981-05-20 1984-01-10 Cornell Research Foundation, Inc. Bovine mastitis vaccine and method for detecting efficacy thereof
US4517394A (en) * 1983-07-05 1985-05-14 W. R. Grace & Co. Preparation of nitro compounds by vapor phase nitration of carboxylic acids
US5178860A (en) 1989-09-01 1993-01-12 Coopers Animal Health Limited Adjuvant complexes and vaccine made therefrom
US4981684A (en) 1989-10-24 1991-01-01 Coopers Animal Health Limited Formation of adjuvant complexes
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2057946A1 (en) * 1990-12-20 1992-06-21 Michael M. Thackeray Electrochemical cell
US5316875A (en) * 1991-07-19 1994-05-31 Matsushita Electric Industrial Co., Ltd. Secondary battery with nonaqueous electrolyte and method of manufacturing same
US5338543A (en) 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
US5585098A (en) 1993-11-23 1996-12-17 Ovimmune, Inc. Oral administration of chicken yolk immunoglobulins to lower somatic cell count in the milk of lactating ruminants
DK0744937T3 (da) * 1994-02-18 2002-10-28 Solidose L L C Vaccination af dyr med tørrede, pelleterede biologiske materialer
JP3702353B2 (ja) * 1996-05-24 2005-10-05 日本電池株式会社 リチウム電池用正極活物質の製造方法およびリチウム電池
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6677082B2 (en) * 2000-06-22 2004-01-13 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
US6680143B2 (en) * 2000-06-22 2004-01-20 The University Of Chicago Lithium metal oxide electrodes for lithium cells and batteries
JP3500424B2 (ja) * 2000-08-31 2004-02-23 独立行政法人産業技術総合研究所 単相リチウムフェライト系複合酸化物
US6548069B2 (en) 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
JP2003513935A (ja) 2003-04-15
US20090263427A1 (en) 2009-10-22
US20070077260A1 (en) 2007-04-05
US20050118200A1 (en) 2005-06-02
BR0015398A (pt) 2002-06-25
AU782508B2 (en) 2005-08-04
US7429389B2 (en) 2008-09-30
US20050053627A1 (en) 2005-03-10
US20080226671A1 (en) 2008-09-18
US20090220550A1 (en) 2009-09-03
AU2622501A (en) 2001-06-06
US7943153B1 (en) 2011-05-17
US20080069842A9 (en) 2008-03-20
US7416734B2 (en) 2008-08-26
WO2001034189A2 (en) 2001-05-17
CA2390613A1 (en) 2001-05-17
MXPA02004627A (es) 2004-02-18
WO2001034189A3 (en) 2001-12-27
ZA200203622B (en) 2003-07-30
EP1229929A2 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
IL162008A0 (en) System and methods for asychronous synchronization
IL138123A0 (en) Medical decision support system and method
EP1206309A4 (en) APPARATUS AND METHOD FOR VIRTUAL SCENING
HUP0103976A3 (en) Novel methods for therapeutic vaccination
HUS1500040I1 (hu) Sztreptokokkusz oltóanyag
AU6079500A (en) Antigen recovery and/or staining apparatus and method
HUP0202885A3 (en) Vaccines
HUP0104914A3 (en) Galenicformulations fast disintegrating the mouth and method for preparing same
AU2279201A (en) Device and method for inserting implants into tissue
HUP0401753A3 (en) Antigen presenting cells, method for their preparation and their use for cancer vaccines
SG91889A1 (en) Protective film and method for preparing same
AU2000238911A1 (en) Hat circulating device and method
ZA200201816B (en) A vaccine composition and method of using the same.
EP1333042A4 (en) STAR BLOCK COPOLYMERS AND METHOD FOR THE PRODUCTION THEREOF
HUP9902217A3 (en) Polycation based bioconjugates and process for producing thereof
AU9567201A (en) Vaccine composition and stabilisation method
EP0956046A4 (en) CELLULAR VACCINALS AND IMMUNOTHERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF
AU2003278175A8 (en) Vaccines of enhanced immunogenicity, and methods for preparing such vaccines
AU5744800A (en) Vaccine formulations and methods for immunizing an individual against shed antigen-specific b cells
IL122587A (en) Mycoplasma synoviae a vaccine comprising same and methods for preparation of the vaccine
IL115521A0 (en) Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same
AU2001237724A1 (en) Method and apparatus for transfer-coating fabric with silicone
GB2350984B (en) Synchronisation method and system
IL132867A0 (en) Epilation method and device
SI1117421T1 (en) Methods for therapeutic vaccination